NEWS
News Articles
GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
Seeking Improved Immune Response vs mRNA Vaccine Full Patient Enrollment Expected Within Six Months ATLANTA, GA, August 10, 2023 — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that vaccinations have begun in an investigator-initiated clinical trial (ClinicalTrials.gov Identifier: NCT05672355) of GEO-CM04S1 in patients…
Read MoreMultiple companies eye Gwinnett’s massive life sciences development [subscription needed]
Gwinnett County’s ambitious, 2,000-acre life sciences campus has seven companies interested, said Mason Ailstock, president of the Rowen Foundation. His foundation is starting to build the Rowen project, which aims to provide a home for research and business development in agriculture, medicine, and environment. The project is located about halfway between Athens and Atlanta and will include…
Read MoreBiotech And The Inflation Reduction Act: Sussing Out The IRA
Source: TD Cowen Insights Podcast – John Murphy, Chief Policy Officer & Healthcare Counsel at the Biotechnology Innovation Organization (BIO) speaks with Yaron Werber, Biotechnology Analyst about how the Inflation Reduction Act (IRA) will impact innovation in biotech. They discuss drug pricing reform provisions of the IRA, including drug exclusion, calculation of maximum fair price, and small molecule vs…
Read MoreAs Part of President Biden’s Unity Agenda, Cancer Moonshot Announces Launch of New ARPA-H Program to Develop Novel Technologies for More Precise and Accurate Cancer Tumor Removal
Program launch represents major milestone for new agency established and funded by President Biden and bipartisan members of Congress to revolutionize how we improve health outcomes for Americans facing cancer and other diseases President’s Unity Agenda also delivering progress in fight against cancer thanks to the Bipartisan Honoring our PACT Act and SERVICE Act, with…
Read MoreSanguina Raises $2.8M in Series A Funding to Drive Innovation in Home-Based Testing and Wellness Management
PEACHTREE CORNERS, Ga.–(BUSINESS WIRE)–Sanguina, a leading biotech company focused on providing rapid home-based testing and management solutions, announced today the successful completion of its $2.8m Series A funding round. Led by Veritus Holdings, the round saw participation from notable investors, including George Hornig of The Seed Lab and Stephen Ippolito of Veritus Holdings. The funding will be…
Read MoreGeoVax Announces Issuance of Ebola Vaccine Patent
Addressing Multiple Strains of Ebolavirus Atlanta, GA, July 24, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the U.S. Patent and Trademark Office has issued Patent No. 11,701,418 B2 to GeoVax, pursuant to the Company’s patent application No. 15/543,139 titled “Replication-Deficient…
Read More